Clinical presentation, course, and prognostic factors in lymphocyte- predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on lymphoma project on lymphocyte-predominant Hodgkin's disease

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 776-783

  Diehl, Volker ^a   Sextro, Michael ^a   Franklin, Jeremy ^a   Hansmann, Martin Leo ^a   Harris, Nancy ^a   Jaffe, Elaine ^a   Poppema, Sibrand ^a   Harris, Martin ^a   Franssila, Kaarle ^a   van Krieken, Jan ^a   Marafioti, Theresa ^a   Anagnostopoulos, Ioannis ^a   Stein, Harald ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0033013787     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.776     Document Type: Article

References (35)

1. Lukes RJ, Butler JJ: The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063-1081, 1966
2. Lukes RJ, Butler JJ, Hicks EB: Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 19:317-344, 1966
3. Colby TV, Hoppe RT, Warnke RA: Hodgkin's disease: A clinicopathologic study of 659 cases. Cancer 49:1848-1858, 1981
4. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
5. Miettinen M, Franssila KO, Saxen E: Hodgkin's disease, lymphocyte predominance nodular: Increased risk of subsequent non-Hodgkin's lymphoma. Cancer 51:2293-2300, 1983
6. Trudel MA, Krikorian JG, Neiman RS: Lymphocyte predominant Hodgkin's disease: A clinicopathologic reassessment. Cancer 59:99-106, 1987
7. Pappa I, Norton AJ, Gupta RK, et al: Nodular type of lymphocyte predominant Hodgkin's disease. Ann Oncol 6:559-565, 1995
8. Hansmann ML, Zwingers T, Boeske A, et al: Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol 108:321-330, 1984
9. Regula DP, Hoppe RT, Weiss LM: Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 318:214-219, 1988
10. Borg-Grech A, Radford JA, Crowther D, et al: A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. J Clin Oncol 7:1303-1309, 1989
11. Crennan E, D'Costa I, Liew KH, et al: Lymphocyte predominant Hodgkin's disease: A clinicopathologic comparative study of histologic and immunophenotypic subtypes. Int J Radiat Oncol Biol Phys 31:333-337, 1995
12. von Wasielewski R, Werner M, Fischer R, et al: Lymphocyte predominant Hodgkin's disease: An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 150:793-803, 1997
13. Bodis S, Kraus MD, Pinkus G, et al: Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol 15:3060-3066, 1997
14. Orlandi E, Lazzarino M, Brusamolino E, et al: Nodular lymphocyte predominance Hodgkin's disease: Long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma 26:359-368, 1997
15. Longo DL, Glatstein E, Duffey PL, et al: Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: Seven-year results of a prospective randomized trial. J Clin Oncol 9:906-917, 1991
16. Brusamolino E, Lazzarino M, Orlandi E, et al: Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Ann Oncol 5:101-106, 1994 (suppl 2)
17. Nordentoft AM, Pedersen-Bjergaard J, Brincker H, et al: Hodgkin's disease in Denmark: A national clinical study by the Danish Hodgkin study group, LYGRA. Scand J Haematol 24:321-334, 1980
18. Henry-Amar M: Second cancer after treatment of Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Ann Oncol 3:117-128, 1992 (suppl 4)
19. Wickert RS, Weisenburger DD, Tierens, et al: Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B-lineage. Blood 86:2312-2320, 1995
20. Greiner TC: Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: Analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 88:657-666, 1996
21. Kanzler H, Hansmann ML, Kapp U, et al: Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L 1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood 87:3429-3436, 1996
22. Bräuninger A, Küppers R, Strickler JG, et al: Hodgkin and Reed-Sternberg cells in lymphocyte predominance Hodgkin's disease represent clonal populations of germinal center-derived tumor cells. Proc Natl Acad Sci U S A 94:9337-9342, 1997
23. Marafioti T, Hummel M, Anagnostopoulos I, et al: Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 337:453-458, 1997
24. Ohno T, Stribley JA, Wu G, et al: Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 337:459-465, 1997
25. Poppema S: The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem 28:788-791, 1980
26. Stein H, Hansmann ML, Lennert K, et al: Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 86:292-297, 1986
27. Kelenyi G: Intracellular J chains in lymphoproliferative diseases. Virchows Arch A Pathol Anat Histopathol 405:365-378, 1985
28. Gough J: Hodgkin's disease: A correlation of histopathology with survival. Int J Cancer 5:273-281, 1970
29. Smetana HF, Cohen BM: Mortality in relation to histiologic subtype in Hodgkin's disease. Blood 11:211-224, 1956
30. Keller AR, Kaplan HS, Lukes RJ, et al: Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer 22:487-499, 1968
31. Soubeyran P, Eghbali H, Trojani M, et al: Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center. Ann Oncol 7:713-718, 1996
32. Cosset JM, Henry-Amar M, Meerwaldt JH: Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience. Ann Oncol 2:77-82, 1991 (suppl 2)
33. Hansmann M-L, Stein H, Fellbaum C, et al: Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 20:1169-1175, 1989
34. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311: 1471-1475, 1984
35. Bastion Y, Sebban C, Berger F, et al: Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15:1587-1594, 1997